619 related articles for article (PubMed ID: 2894877)
21. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
Ignarro LJ; Byrns RE; Buga GM; Wood KS
Circ Res; 1987 Dec; 61(6):866-79. PubMed ID: 2890446
[TBL] [Abstract][Full Text] [Related]
22. Impaired relaxing response to isoprenaline in isolated thoracic aorta of nephrotic rats: decrease in release of EDRF from endothelial cells.
Ito M; Yamamoto I; Naruse A; Suzuki Y; Satake N; Shibata S
J Cardiovasc Pharmacol; 1997 Feb; 29(2):232-9. PubMed ID: 9057073
[TBL] [Abstract][Full Text] [Related]
23. Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture.
Marczin N; Ryan US; Catravas JD
Am J Physiol; 1992 Jul; 263(1 Pt 1):L113-21. PubMed ID: 1379001
[TBL] [Abstract][Full Text] [Related]
24. Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells.
Leitman DC; Andresen JW; Catalano RM; Waldman SA; Tuan JJ; Murad F
J Biol Chem; 1988 Mar; 263(8):3720-8. PubMed ID: 2894373
[TBL] [Abstract][Full Text] [Related]
25. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
26. Impaired cyclic nucleotide-mediated vasorelaxation may contribute to closure of the human umbilical artery after birth.
Renowden S; Edwards DH; Griffith TM
Br J Pharmacol; 1992 Jun; 106(2):348-53. PubMed ID: 1327377
[TBL] [Abstract][Full Text] [Related]
27. Effect of calcium on endothelium-derived relaxing factor formation and cGMP levels in endothelial cells.
Schmidt K; Mayer B; Kukovetz WR
Eur J Pharmacol; 1989 Nov; 170(3):157-66. PubMed ID: 2559853
[TBL] [Abstract][Full Text] [Related]
28. Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery.
Bucher B; Ouedraogo S; Tschöpl M; Paya D; Stoclet JC
Br J Pharmacol; 1992 Dec; 107(4):976-82. PubMed ID: 1334757
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of inositol 1,4,5-trisphosphate formation by cyclic GMP in cultured aortic endothelial cells of the pig.
Lang D; Lewis MJ
Br J Pharmacol; 1991 Jan; 102(1):277-81. PubMed ID: 1646060
[TBL] [Abstract][Full Text] [Related]
30. Correlation between airway epithelium-induced relaxation of rat aorta in the co-axial bioassay and cyclic nucleotide levels.
Hay DW; Muccitelli RM; Page CP; Spina D
Br J Pharmacol; 1992 Apr; 105(4):954-8. PubMed ID: 1324058
[TBL] [Abstract][Full Text] [Related]
31. Effects of glyceryl trinitrate on endothelium-dependent and -independent relaxation and cyclic GMP levels in rat aorta and human coronary artery.
Rapoport RM; Waldman SA; Ginsburg R; Molina CR; Murad F
J Cardiovasc Pharmacol; 1987 Jul; 10(1):82-9. PubMed ID: 2441158
[TBL] [Abstract][Full Text] [Related]
32. Modulation of arterial endothelial permeability: studies on an in vitro model.
Gudgeon JR; Martin W
Br J Pharmacol; 1989 Dec; 98(4):1267-74. PubMed ID: 2514947
[TBL] [Abstract][Full Text] [Related]
33. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase.
Mülsch A; Busse R; Liebau S; Förstermann U
J Pharmacol Exp Ther; 1988 Oct; 247(1):283-8. PubMed ID: 2902213
[TBL] [Abstract][Full Text] [Related]
34. Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture.
Doni MG; Whittle BJ; Palmer RM; Moncada S
Eur J Pharmacol; 1988 Jun; 151(1):19-25. PubMed ID: 3046956
[TBL] [Abstract][Full Text] [Related]
35. Glyceryl trinitrate increases platelet cyclic GMP after metabolism in fibroblasts.
Kuhn M; Otten A; Frölich JC; Förstermann U
Eur J Pharmacol; 1991 Jul; 200(1):175-8. PubMed ID: 1685121
[TBL] [Abstract][Full Text] [Related]
36. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
Komas N; Lugnier C; Stoclet JC
Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
[TBL] [Abstract][Full Text] [Related]
37. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.
Marczin N; Ryan US; Catravas JD
J Pharmacol Exp Ther; 1992 Oct; 263(1):170-9. PubMed ID: 1328604
[TBL] [Abstract][Full Text] [Related]
38. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
Murad F; Waldman S; Molina C; Bennett B; Leitman D
Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
[TBL] [Abstract][Full Text] [Related]
39. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
40. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
Yu SM; Cheng ZJ; Kuo SC
Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
